Whats new
Whats new.
Maxim - Positive Response Data from INSIGHT-003 in 1L NSCLC; Bodes Well for Ongoing P3 Pivotal TACTI-004 Study - Rated Buy, US$12 PT (Analyst: Jason McCarthy, Ph.D.)
May 16th 2025
For a copy of this analyst report please contact your Maxim advisor